Testing new antiviral agents against respiratory viruses like SARS-CoV-2.
Task B25: In Vitro Assessment for Antimicrobial Activity Against Respiratory Viruses, SARS-CoV-2
['FUNDING_OTHER'] · UTAH STATE UNIVERSITY · NIH-11202355
This study is looking at new medicines that might help fight respiratory viruses like COVID-19, and it could lead to better treatments for patients dealing with these infections.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UTAH STATE UNIVERSITY (nih funded) |
| Locations | 1 site (LOGAN, UNITED STATES) |
| Trial ID | NIH-11202355 on ClinicalTrials.gov |
What this research studies
This research focuses on evaluating the effectiveness of potential antiviral agents against respiratory viruses, specifically SARS-CoV-2, through laboratory testing. It involves maintaining viral stocks and cell lines necessary for growing the viruses and developing assays to measure the antiviral activity. Patients may benefit from this research as it aims to identify new treatments that could help combat COVID-19 and similar respiratory infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are at risk of severe respiratory viral infections, including those with underlying health conditions.
Not a fit: Patients who are not at risk for respiratory viral infections or those who have already recovered from COVID-19 may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antiviral treatments for COVID-19 and other respiratory viruses.
How similar studies have performed: Other research has shown success in developing antiviral agents against respiratory viruses, indicating that this approach has potential.
Where this research is happening
LOGAN, UNITED STATES
- UTAH STATE UNIVERSITY — LOGAN, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HURST, BRETT — UTAH STATE UNIVERSITY
- Study coordinator: HURST, BRETT
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.